Barry Goldstein
Management
Thanks, Amanda, and good morning, everyone. We are pleased you can join us on this, our year-end 2020 conference call. We’re going to mix it up a bit today. I recognize these calls are intended to lend color and perspective to our historical results, as well as to our future. Scott, our new CFO, will review the results with you, and Meryl will discuss our operations, and in particular, our Kingstone 2.0 initiative, which is ongoing and which will propel us forward. For me, I'm going to go in a bit of a different direction. I have many responsibilities at Kingstone, but none more important than guiding the allocation of capital to preserve and enhance the investment entrusted to us by our shareholders. And ultimately, our share price should reflect how well we've done and how well we are expected to do. But in short, in my opinion, it doesn't. We had a rough patch to get through when I returned to CEO in mid-2019. I made the difficult decision to exit the commercial liability lines that were requiring more and more of our capital, but which were doing poorly. I didn't make many friends by doing this, but this was 100% the correct action to take. Now, as we go forward, all of our surplus can be deployed in support about personal lines, with a life of the claim is far shorter and the volatility is far less. Unfortunately, even though the lines we exited were never more than 15% of our business, the issues attendant to the exit brought much pain to our shareholders, as the stock price suffered greatly. I said then and I feel the same now that the share price decline was exaggerated. And by the way, no one felt the pain more than me, as the company's largest holder. I hope that the favorable results we are generating will now take over the spotlight. Last year, many important metrics improved. We ended the year with book value at an all-time high. We earned over $1 a share in operating profits, excluding catastrophe losses. But while our share price has recovered to a certain extent, we're still trading at a discount to book value and well below our intrinsic value.